09.04.2018 – 13:00NorgineNHS England to Fund Endocuff Vision® for Cancer Screening Colonoscopies BowelAmsterdam (ots/PRNewswire) - Norgine B.V. today announced that its UK affiliate has received funding for ENDOCUFF VISION® through the NHS Innovation Technology Payment 2018/19 (ITP) scheme. The NHS ITP Programme aims to support the NHS in adopting innovation by removing financial or procurement barriers to uptake of innovative products or technologies and ...
20.02.2018 – 15:02InSightecIsrael Ministry of Health Includes INSIGHTEC's Focused Ultrasound Treatment for Medication-Refractory Essential Tremor as Part of Covered Health ServicesHaifa, Israel and Miami (ots/PRNewswire) - INSIGHTEC®, a commercial-stage medical technology company revolutionizing surgery with incisionless MR-guided focused ultrasound (MRgFUS) announced today that the Neuravive focused ultrasound treatment will be a covered service for essential tremor patients in Israel. The ...
19.10.2017 – 13:32AccurayEuropean Court of Appeal Rejects Varian's Attempt to Reverse Customer Purchase of Accuray TomoTherapy® SystemSunnyvale, California (ots/PRNewswire) - Accuray Incorporated (NASDAQ: ARAY) announced today that the Court of Appeal of Nantes has rejected the appeal filed by Varian Medical Systems opposing the purchase of the Accuray TomoTherapy® System by University Hospital of Tours (CHU). This most recent legal ruling marks ...
24.02.2016 – 01:02Astellas Pharma Europe LimitedBritain Facing Social Care 'Time-bomb' with Thousands of People Underprepared to Look After Themselves in Old AgeChertsey, England (ots/PRNewswire) - Experts say the knock-on effect of lack of planning for later life, as highlighted in poll conducted for this year's ASTELLAS INNOVATION DEBATE[TM],will further impact upon stretched NHS resources Results from a new survey for the annual Astellas Innovation Debate have ...
